Efficacy and Safety of Omalizumab in Patients With Severe Persistent Asthma
NCT00046748 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 484
Last updated 2017-08-02
Summary
The purpose of this study is to determine the effect of omalizumab, compared to placebo, on clinically significant asthma exacerbation rates in adolescents and adults with asthma.
Conditions
Interventions
- DRUG
-
Omalizumab
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-12-31
- Primary Completion
- 2004-04-30
- Completion
- 2004-04-30
More Related Trials
-
Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma
NCT00079937 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma
NCT01716754 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Omalizumab in Patients With Severe Persistent Non-atopic Uncontrolled Asthma
NCT01007149 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma
NCT00180011 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study to Assess the Efficacy and Safety of Omalizumab Treatment on ICS Reduction for Severe IgE-mediated Asthma
NCT01912872 ·Status: TERMINATED ·Phase: PHASE4
-
A Study of Omalizumab in the Prevention of Allergen Induced Airway Obstruction in Adults With Mild Allergic Asthma
NCT00434434 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Omalizumab (Xolair) in Subjects With Moderate to Severe Persistent Asthma (EXTRA)
NCT00314574 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability of Omalizumab in Poorly Controlled Moderate to Severe Asthma Patients
NCT00482508 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective, Randomized, Double-Blind Study of the Efficacy of Omalizumab (Xolair) in Atopic Asthmatics With Good Lung Capacity Who Remain Difficult to Treat (EXACT)
NCT00096954 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Tolerability of Omalizumab in Patients With Mild to Moderate Asthma
NCT00546143 ·Status: COMPLETED ·Phase: PHASE4
-
Omalizumab in Non-atopic Asthma
NCT01113437 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term Therapy
NCT01125748 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Tolerability of Omalizumab in Adults and Adolescents With Severe Allergic Asthma
NCT00482248 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Omalizumab in Moderate to Severe Bronchial Asthma
NCT00232050 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic Asthma
NCT01703312 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Preventing Asthma in High Risk Kids
NCT02570984 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Safety and Efficacy Study of Omalizumab to Treat Allergic Asthma
NCT01976208 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety, Tolerability, and Pharcodynamics of AMG 853 in Adolescents With Asthma
NCT01137565 ·Status: COMPLETED ·Phase: PHASE1
-
The Study of Omalizumab (CMAB007 and Xolair) in Healthy Subjects to Compare the PK, PD and Safety
NCT04778137 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair)
NCT01922037 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety and Efficacy Study of Mepolizumab in Subjects With Severe Asthma
NCT03562195 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Omalizumab in Preventing Bronchoconstriction Following Environmental Cat Dander Exposure in Patients With Cat Dander-induced Asthma
NCT00495612 ·Status: COMPLETED ·Phase: PHASE4
-
Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma
NCT00567476 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Omalizumab on Expression of IgE Receptors in Adults With Severe, Inadequately Controlled Allergic Asthma
NCT00454051 ·Status: COMPLETED ·Phase: PHASE4
-
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
NCT01430403 ·Status: COMPLETED ·Phase: PHASE4